We have investigated the transport of L-and D-triiodothyronine (T3) from plasma to cellular cytoplasm and from cytoplasm to nucleus by estimating the concentration of free hormone in these compartments in rat liver, kidney, brain, and heart. We assessed the distribution of T3 in various tissues and its metabolism by standard isotopic techniques and measured plasma and cytosolic tissue T3 by radioimmunoassay. In addition, we determined the fraction of radioactive T3 associated with the cytosol in individual tissues and estimated the cytosolic volume per gram of tissue. Equilibrium dialysis allowed us to determine the binding power of cytosols and plasma, and in vitro saturation techniques provided values for the affinity (k.) for L-and D-T3 of isolated nuclei in aqueous solution at 370C.
Introduction
Although there is substantial evidence pointing to a rapid exchange of triiodothyronine (T3)' between plasma and cellular pools and among subcellular components (1) , the basic mechanisms responsible for the establishment of such equilibrium relationships remain ill-defined. In particular, there has been considerable controversy as to whether the exchange of T3 between cells and their milieux is a function of simple diffusion or whether mediated transport, either active or facilitated, is involved. Lein and Dowben (2) at first proposed that because of the lipophilic properties of T3, the partition between T3 and cells could be explained by simple diffusion. On the other hand, Rao and co-workers (3, 4) have challenged this viewpoint and have concluded from their studies in isolated hepatocytes that, in part, such transfer represents a saturable process which can be retarded by certain metabolic inhibitors. Krenning and colleagues have reached essentially similar conclusions (5, 6) . More recently Cheng et al. have proposed that in cultured fibroblasts receptor-mediated transport is involved in the exchange process (7, 8) . The applicability of these findings to the exchange process that occurs in vivo however, has not been specifically examined.
In contrast, it is generally agreed that the equilibration between nucleus and cells is determined by simple diffusion, and the steady state partition by the binding characteristics of the individual compartments. Studies with isolated nuclei have failed to reveal a requirement for a specialized transport system or the expenditure of metabolic energy (9) . However, it is not clear whether this in vitro model is applicable to the in vivo processes in the intact animal.
Recent experiments with 125I-labeled D-and L-T3 in our laboratory have stimulated our interest in examining both of these questions (10) . These studies showed a high degree of stereospecificity in the entrance of L-and D-T3 into various tissues. Our studies also showed for the first time that there is a remarkable degree of specificity in the accumulation of L-as compared with D-T3 by nuclei of various cells in the intact animal. These observations contrasted strongly with the relative lack of specificity in the binding of these enantiomers in vitro. The enhanced accumulation of L-T3 in vivo appeared to account for the greater biologic potency of the L-form.
Since both enantiomers of T3 have similar physical and chemical characteristics, it occurred to us that these substances could be used as effective probes in examining the mechanism that underlies T3 transport and exchange processes. Furthermore, by estimating the concentration of free hormone in plasma, cytosol, and nucleus we attempted to determine the presence or absence ofsignificant gradients, which might reflect the participation of active metabolic processes in transport.
Methods
Male Sprague-Dawley rats weighing 175-200 g were purchased from BioLab Corp. (St. Paul, MN). The animals had free access to food (Purina rat chow; Ralston Purina Co., St. Louis, MO) and water. ng/I00 g body wt) were injected via the tail vein. Animals were killed at intervals from 5 brain, 0.024; heart, 0.117; kidney, 0.102; and liver, 0.102. For liver and kidney the binding for T3 was strong enough so that the correction was <2% and could be safely ignored. Levels of nonspecifically bound '251I-labeled hormone in nuclei were determined for all tissues in animals injected with loading doses, 20 ;tg/I00 g body wt, of unlabeled hormone together with the radiolabeled tracer dose and killed 3 h later. The nuclear/plasma isotopic concentration ratio measured in this group was then subtracted from that observed at all times. The corrected nuclear/plasma isotopic ratio was taken to represent the ratio of specifically receptor bound T3 in the nucleus to that in plasma. DNA concentrations were measured by the Burton procedure as modified by Giles and Meyers (14) .
In order to determine the fraction of intracellular [125111> T3 associated with cytosol, animals were injected intravenously with tracer doses (<5 ng/100 g body wt) of one radiolabeled enantiomer or the other. After 2 h, rats were killed and tissues excised. 10%
homogenates were prepared in 0.32 M sucrose-3 mM MgCl2 and an aliquot was taken for radioactive assay. Cytosol was prepared by centrifugation in a 70.1 Ti rotor at 160,000 g for 60 min. The clear cytosol was separated and a measured aliquot was counted. All procedures were carried out at 2-4°C. Again, corrections were made in brain and heart for trapped plasma under the assumption that all plasma would be associated with the cytosol fraction.
Equilibrium dialysis was performed as previously described (15 The volume of cytosol contained in a gram of tissue was measured by isotopic dilution. I g of tissue was homogenized in 3 ml of 0.32 M sucrose-3 mM MgCl2 containing 0.1 Ci of 125I-albumin. The homogenate was centrifuged at 160,000 g for 60 min and I ml of the clear supernatant was taken for radioactive assay. Since essentially all labeled albumin is distributed to the cytosol, the ratio of the '251I-albumin added in the starting homogenizing medium to the final cytosolic concentration yields the volume of cytosol.
Assays of nuclear T3 receptor were performed as described by Schuster et al. by the use of isolated nuclei (16) . Binding capacity and association constants were calculated from Scatchard analyses of the binding data.
Calculations
The model system used for the interrelationship between cells and plasma and between nuclei and cytosol is based on generally accepted views and is schematically represented in Fig. 1 (17, 18) .
Concentration gradients offree T3 between cytosol and plasma. The tissue/plasma isotopic concentration ratio (T/P*) was calculated for each tissue at the equilibrium time point, previously defined as the peak value in the nuclear radioactivity concentration curve (13) . At this point, the specific activity of plasma-derived T3 and tissue T3 can be presumed to be identical, and the nonradioactive tissue/plasma concentration ratio, T/P, to equal *T/*P. Because there is a broad plateau achieved by brain and heart, the values between 1 and 6 h were averaged.
We have previously (19) defined the binding power (bp) per gram as (I -DF/DFh, where DF is the dialysis fraction of the serum, and y is the dilution factor. One can define the binding power of cytosol, bc, in an analogous fashion. 1 g of tissue was diluted 20-fold during homogenization and the cytosol was diluted 4-fold more for dialysis. Since the cytosol constitutes only a fraction of the tissue radioactivity, the value 80/Vc was assumed to be y, where Vc is the estimated volume of the cytosol per gram tissue. Theoretical considerations suggest that the binding power is proportional to dilution (20) , and this was confirmed by the demonstration of comparable binding power values when 1 g of homogenate was brought to both 40 and 80 ml.
The fraction of total radioactive T3 associated with the cytosol, Pc, was determined by subcellular fractionation as described above. We calculated the gradients of free cytosolic T3, Fc, to the concentration of free hormone in plasma, Fp (1) (2) (3) Measurement ofthefree cytosolic T7' concentration by radioimmunoassay (RIA) and isotopic techniques. Four animals were injected with tracer ['25IJT3 and killed 2 h later. At this point the tissue/plasma ratio is not different from that at the equilibrium time point for liver, and the level of radioactive T3 in other tissues is close to the equilibrium time point. These considerations allow the assumption of identical specific activities for plasma-derived tissue T3 and plasma T3.
Liver, heart, brain, and kidney were excised and I g of tissue was homogenized with 4 ml of 0.32 M sucrose-3 mM MgCI2. Cytosol was prepared as described above. An aliquot of cytosol and serum was taken for assay of total 1251 content. A second aliquot was extracted with absolute ethanol containing 10' M propylthiouracil until at least 90% of counts were extracted. The extract was concentrated and applied to a paper chromatogram to determine the ['23IJT3 content.
The concentration of T3 in cytosol was computed from the product of the ['25I]T3 cytosol/plasma ratio and the concentration of immunoassayable T3 in the plasma. In the same serum and cytosolic fraction, we determined the level of T3 by RIA using the technique of Surks et al. (21) . In preliminary experiments we had determined that T3 could be readily measured in the cytosol, as verified by excellent recovery of added T3 without the requirement of a correction blank. To calculate the concentration of total T3 in undiluted cytosol, we multiplied the concentration of T3 in the diluted cytosol by the dilution factor, which was estimated to be (4 + Vc)/lV, where 4 represents the volume of buffer added per gram tissue, and Vc represents the estimated volume of cytosol per gram tissue. Finally, the concentration of free L-T3 could be estimated by division of the molar concentration of T3 in cytosol by bc, the binding power of cytosol as determined above.
Estimation ofthe nuclearfree Tj concentration (FNJ. A substantial body of information points to a reversible association of T3 with specific nuclear nonhistone receptor sites (22). Moreover, there appears to be only one component upon Scatchard analysis of such receptor sites (16, 23) . From the Law of Mass Action,
where T3N is the molar concentration of the T3 nuclear receptor complex, M is the maximal binding capacity, and k, is the association constant of the nuclear sites as determined in vitro at 37°C (16) . T3N/ M -T3N represents the ratio of bound to free receptor sites. This could be derived for liver, kidney, and heart from our previous saturation studies in the intact rat (13) . Because of the important contribution of local thyroxine (T4) to T3 conversion in brain, we estimated this term in brain from the data recently presented by Crantz et al. (24) . 
The values for #L and AlD were computed and are listed in Table IV; the values for k.D and kA1L were defined by Scatchard analysis of isolated nuclei. The ratio FNL/FCL listed in Table V can be obtained from the quotient of FNL (Table III) and F0. (Table II ). The ratios NtIC* and N*e/C* were determined in experiments over 24 h. After 0.5 h, the N*/C* ratio for all tissues was the same in all subsequent periods, which indicates rapid intracellular equilibration (18 (Table I ).
An analysis of the D-T3 results shows an even more striking difference among the tissue/plasma ratios in the four tissues (Table II) . The cytosolic content of T3 derived from plasma can be determined from the product of the ratio of radioactive T3 in cytosol to radioactive T3 in plasma at the equilibrium time point and the concentration of T3 in plasma as determined by RIA. Alternatively, the total T3 content in cytosol can be measured by direct RIA. The data presented in Table II show an excellent correspondence between the total T3 content and the plasma-derived T3 in liver, kidney, and heart but indicate that the level of L-T3 in brain is substantially higher than that derived from plasma. These findings are precisely what one would anticipate from the earlier studies of Crantz et al. (24) , who showed that -70% of brain T3 is derived from local T4-to-T3 conversion and that only the remaining 30% of the total cellular T3 is derived from plasma. In contrast, the same group showed that virtually all of the T3 in liver, kidney, and heart was derived from the plasma (25) . As indicated in Table I , the binding power of cytosol of liver and kidney as determined by equilibrium dialysis was six-to sevenfold greater than that exhibited by plasma protein, whereas the binding by heart and brain cytosol was slightly less than that of plasma. The calculated free T3 concentrations in liver, kidney, heart, and plasma based both on the direct RIA and the equilibrium dialysis varied over a remarkably small range as compared with the range of total cytosolic T3 among the various tissues and plasma compartments analyzed. Thus, despite an almost 10-fold higher concentration oftotal T3 in liver than in plasma, the concentration of free T3 in cytosol was only 1.8-fold greater than that in plasma (Table II) . The free cytosolic T3 concentration of brain, however, was estimated to be 4.0-fold higher than that of plasma and 2.3-fold higher than the concentration of free cytosolic T3 in liver. The high ratio of free hormone in brain cytosol to that in plasma probably reflects the active local production of T3 from T4 in this tissue and a relatively slow equilibration of free T3 between plasma and cytosol. Nuclear/cytoplasmic free hormone gradients. The calculated free L-T3 concentration in the nucleus in each of the tissues was exceedingly high in relationship to the estimated free cytosolic T3 concentration. The ratio between nuclear and cytoplasmic free T3 concentrations was highest in brain with a value of 251 and, in descending order, of 80, 58, and 56 for heart, liver, and kidney, respectively. These gradients cannot be explained simply on the basis of statistical error. If our underlying assumptions are correct, they must represent the effect of an intracellular energy-requiring transport process. A vigorous transport process in brain appears to lead to the high degree of nuclear occupancy in this tissue, as first reported by Crantz et al. (24) .
The data generated in our study have also allowed us to calculate the concentration gradient of free D-TI between nucleus and cytosol. The derivation of the equations used in these estimates is provided in Methods. The component factors and the results of the calculations are listed in Binding capacity was calculated from Eq. 9 by use of data in Tables  III and IV. nuclear and extranuclear compartments. Our results extend our previous findings, which indicate a stereospecific uptake of L-T3 by liver and heart nuclei in the living animal despite the similar nuclear affinities for these enantiomers in vitro (10) . The present report clearly shows that the differential accumulation of these enantiomers is highly characteristic of a given tissue but that in each there is a preferential nuclear uptake of the L-enantiomer in the intact animal. Our analysis suggests the existence of two stereospecific transport systems, one leading to the accumulation of L-and D-T3 by the cells as a whole and the other involved in the selective concentration of L-T3 by the nuclei. Our conclusions are based on the estimation of the equilibrium free hormone concentrations in plasma, cytosol, and nucleus and the assumption of the exchange processes represented in Fig. 1 . We assumed that the selective accumulation of radioactive D-and L-T3 by specific cellular and subcellular compartments is a function both of the concentration of free aqueous hormone with which specific particulate components equilibrate and of the specific binding characteristics of such compartments. In order to determine the concentration of free hormone in plasma, conventional equilibrium dialysis was performed and the mass of circulating total T3 was determined by RIA. Similarly, we estimated the concentration of free T3 in the nuclear fraction from the results of the Scatchard analysis of isolated nuclei and the known fractional nuclear occupancy in euthyroid animals. We have also assumed that the cytosolic component measured represents a uniform compartment that is in direct kinetic contiguity with the nucleus. We further assumed that there is no significant redistribution of radioactivity from one fraction to another in the course of subcellular fractionation. In previous studies, we have provided evidence that such redistribution does not occur between nuclear and extranuclear compartments at 00C (9) . In more recent preliminary experiments we have also shown that the rate of dissociation of T3 from the particulate fraction is slow enough at 00C so as not to introduce any serious error into our calculation.
Even if, for the sake of argument, we assumed to be true the unlikely possibility that all of the cellular radioactivity in the non-nuclear fraction is concentrated in the cytosol, there would remain an important gradient of free T3 between the nuclear and cytoplasmic compartments.
Our findings have also shown that the preferential uptake of D-T3 by the kidney and liver as a whole cannot be attributed to preferential binding of the D-enantiomer by any of the major subcellular constituents. To the contrary, the cytosolic proteins bound L-more avidly than D-T3. Similarly, from the fractional distribution of radioactive T3 in the other subcellular fractions, we inferred that there was no preferential binding of D-T3 by any subcellular fractions. These considerations are simply another way of stating our basic conclusion that, in liver and kidney, preferential uptake of D-T3 is due to the operation of a stereospecific transport system responsible for the translocation of D-T3 from plasma to cytosol.
The preferential accumulation of D-T3 by liver and kidney contrasts markedly with the results in brain and heart. In heart, the free L-and D-T3 cytosol/plasma gradients were similar and only slightly greater than 1.0, whereas we consistently showed a reverse cytosol/plasma gradient in brain with a value of 0.32 for D-T3, a value significantly less than 1.0.
Our Despite the obvious stereospecific factors involved in the transport of L-T3 from plasma to cytosol there is remarkably little alteration in the partition of L-T3 between plasma and cells with increasing doses of L-T3. Only with very large doses of the D-enantiomer was it possible to inhibit to some extent the fractional accumulation of this iodothyronine by kidney and liver (data not shown). Our in vivo findings with L-T3 contrast markedly with other reports of in vitro systems, suggesting that there is participation of limited capacity, high affinity binding sites (3) (4) (5) (6) . Moreover, the lack of effect of large doses on transport makes it difficult to determine that facilitated transport is involved. Our data are perhaps most compatible with the concept that there is a virtual infinitude of stereospecific binding sites involved in transmembrane transport. The possibility should also be considered that there are two processes involved in T3 transport, simple diffusion for L-T3 which may not be stereospecific and a specialized transport system involved in the movement of D-T3. However, the finding of cytosolic/plasma gradients of free T3 < 1.0 in brain would be incompatible with the concept of free diffusion in this cell type. It is intriguing to speculate about a possible relationship between D-T3 accumulation by liver and kidney and the well-known presence of D-amino oxidases in these tissues.
In contrast to the modest cytosolic/plasma free L-T3 ratios in the various tissues analyzed, our results point to a very steep free T3 gradient from cytosol to nucleus. Our calculation of the free L-T3 concentration in the nucleus is based on the generally accepted assumption that there is a reversible equilibrium between free T3 and T3 bound to the specific nuclear sites. We can estimate the ambient free T3 concentration in the nucleus from the association constant as determined by saturation analysis of isolated nuclei at 37°C and the fraction of the total sites occupied under euthyroid conditions. The nuclear/cytosolic free T3 ratios calculated in this fashion varied from 57 in kidney to 251 in brain. Such high values suggest the participation of active transport in establishing these gradients.
The establishment of a gradient from cytosol to nucleus may explain the discrepancy between the estimates of nuclear affinity for L-T3 based on equilibration experiments in the intact animal and the results of in vitro measurements in isolated nuclei or solubilized receptors incubated at 370C. Thus, in our earlier studies we estimated that the nuclear affinity of T3 was 4.7 X 10" M-l, whereas the in vitro estimates by us and others show a range of -5 X 108 to 5 X 109 (9, 16, 26, 27) . For in vivo calculations, however, we tacitly assumed that the concentration of free T3 throughout the cell was uniform and equivalent to the concentration of free T3 in the plasma. In addition, the concept that exchange of free T3 between cytosol and nuclear compartment proceeds by simple diffusion was buttressed by the rapid equilibration of T3 in medium with specific receptors in isolated nuclei in vitro. In such preparations, addition of metabolic inhibitors had no effect on the partition of T3 between specific nuclear sites and the medium (9) .
The present set of experiments has induced us to revise our concepts of the mechanism underlying the exchange process in vivo. The exchange of T3 with nuclei in vitro probably is not an appropriate model for the exchange in the living animal. Thus, in vitro exchange probably is a result of simple diffusion and is not contingent upon the expenditure of metabolic energy. In the intact cell, however, such a diffusion process either does not occur at all or is supplemented by energy-producing processes. Presumably, in the process of subcellular fractionation, the structural basis of the mechanism responsible for T3 transport from cytosol to nucleus is disrupted.
The precise nature of the transport mechanism responsible for the cytosolic/nuclear gradient remains speculative. There is very little precedent for other transport systems involved in the translocation of ions, metabolites, and other hormones from the cytosol to the nucleus. However, an earlier report by Alfrey et al. suggested that active transport of amino acids between cytosol and nucleus depended upon the activity of Na-K ATPase (28). Since these studies were carried out before the development of current methods for subcellular fractionation techniques, it is conceivable that some of the results may have been due to contaminating subcellular fractions. On the other hand, it appears equally plausible that the methods now used for separating nuclei result in the detachment of important components involved in the putative transport mechanisms.
The nuclear/cytoplasmic free hormone ratio for D-T3 was estimated from Eq. 10 and thus depended upon the assumption of multiple biologic constants. Nevertheless, the results given in (13) . The general internal consistency of these data support the validity of the underlying assumptions and approaches used in these studies.
Finally, an alternative explanation for our nuclear data should be considered, namely that the binding affinity of the nuclear sites as determined in vitro represents a marked underestimation of the affinity operative under in vivo conditions. One could postulate that essential ionic and metabolic elements present in the nucleus under in vivo conditions are removed in the process of subcellular fractionation. Such an explanation, however, does not seem likely for the following reasons. One would be compelled to postulate that subcellular fractionation resulted not only in diminished affinity but also in a loss of stereospecificity. Moreover, if subcellular fractionation had resulted in a 50-fold loss in affinity of the specific sites it would be impossible to detect the receptor in in vitro incubation experiments. The ratio of specific to nonspecific binding both in vivo and in vitro is -20 to 1. Nevertheless, rigorous elimination of this possibility must await the development of specific in vitro systems that will allow direct study of the transport system and the ability of specific reagents to inhibit such a transport system.
The nuclear transport system may be regulated under a variety of pathophysiological conditions. Thus, our results may have important clinical implications. Previous reports have suggested that the peripheral thyroid hormone resistance of tissues, for instance, may be due to a defect in cellular transport of hormone (29, 30) . The possibility that defects occur in nuclear transport should also be considered. Our findings may be relevant to the pharmacologic problem of developing analogues with selective tissue effects. Our data indicate that despite previously reported agreement between biologic activity and nuclear binding (22), appropriate comparison of thyroid hormone analogues can only be made by reference to in vivo systems. This has been demonstrated not only by this report but by studies carried out by Emmet and co-workers (31) . Thus, differential penetration of the cytoplasm and the nucleus by thyroid hormone analogues must be taken into account in correlating hormonal biologic effects with nuclear occupancy. We should also consider the possibility that analogous transport systems are involved in the transport of other hormones and metabolites to the nucleus.
